- ISIN DE000A2YNT30
- Country Deutschland
Latest Research
News Functions
Additional Functions
2 May 2024
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
21 March 2024
Alzchem Group AG
Original-Research: Alzchem Group AG (von Alzchem Group AG): Buy
4 March 2024
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
27 October 2023
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
19 October 2023
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
7 August 2023
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
5 May 2023
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
2 March 2023
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
27 October 2022
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
27 July 2022
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
2 May 2022
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
25 April 2022
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
28 February 2022
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
15 November 2021
Alzchem Group AG
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
Latest News
News Functions
Additional Functions
7 May 2024
Alzchem Group AG
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
30 April 2024
Alzchem Group AG
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
25 March 2024
Alzchem Group AG
Alzchem Group AG: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2024 in Trostberg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
15 March 2024
Alzchem Group AG
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
11 March 2024
Alzchem Group AG
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
1 March 2024
Alzchem Group AG
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
Upcoming Events
Event Functions
Additional Functions
Latest Reports
News Functions
Additional Functions
4 April 2024
Alzchem Group AG
Annual financial report 2023
Alzchem Group AG
Jahresfinanzbericht 2023
13 November 2023
Alzchem Group AG
Q3 statement / Q3 financial report 2023
17 August 2023
Alzchem Group AG
Half-yearly financial report 2023